“Anti-SARS-CoV-2 Inactivated Vaccine in Patients With ANCA-Associated Vasculitis: Immunogenicity, Safety, Antibody Decay and the Booster Dose”. Clinics 78 (November 29, 2022): 100150. Accessed May 9, 2024. https://www.journals.usp.br/clinics/article/view/213657.